The Innovative Medicines Initiative 2 Joint Undertaking has been created1 following the principles below: Research related to the future of medicine should be undertaken in areas where societal, public health and biomedical industry competitiveness goals are aligned and require the pooling of resources and greater collaboration between the public and private sectors, with the involvement of small and medium-sized enterprises.
Diabetes represents an increasing global healthcare challenge. Controlling blood glucose is a cornerstone in diabetes management aiming to reduce the increased morbidity and mortality associated with this disease. However, only around 50% of patients achieve accepted international glycaemic targets. Whilst the reasons behind this are multifactorial, it is well recognised that episodes of hypoglycaemia (low blood glucose levels) and the resulting fear of hypoglycaemia are significant barriers to achieving better glycaemic control.
- Topic 1: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials
- Topic 2: How big data could support better diagnosis and treatment outcomes for prostate cancer (part of the Big Data for Better Outcomes programme)
- Topic 7: Patient perspectives in medicines lifecycle
- Topic 8: Personalised medicine approaches in autism spectrum disorders
For more information for partners and Fund subscribe to the Billetin PROJECT AND FUND
Price for 1 year € 120
6 months € 60